LFVN logo

LifeVantage Corporation (LFVN)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

LifeVantage Corporation (LFVN) trades at $4.32 with AI Score 54/100 (Hold). LifeVantage Corporation develops and distributes nutrigenomic activators, dietary supplements, and skincare products through a network of independent distributors. Market cap: 56M, Sector: Consumer defensive.

Last analyzed: Feb 8, 2026
LifeVantage Corporation develops and distributes nutrigenomic activators, dietary supplements, and skincare products through a network of independent distributors. The company operates in multiple international markets, focusing on science-backed wellness solutions.
54/100 AI Score Target $5.00 (+15.7%) MCap 56M Vol 27K

LifeVantage Corporation (LFVN) Consumer Business Overview

CEOSteven R. Fife
Employees222
HeadquartersLehi, UT, US
IPO Year1994

LifeVantage Corporation (LFVN) pioneers nutrigenomic solutions, offering scientifically validated dietary supplements and skincare products through a global network of independent distributors, capitalizing on the growing demand for personalized wellness and anti-aging solutions with a compelling dividend yield of 3.48%.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Feb 8, 2026

Investment Thesis

LifeVantage Corporation presents a notable research candidate due to its focus on the growing nutrigenomics market and its established direct selling distribution network. The company's commitment to scientifically validated products, such as Protandim, provides a competitive edge in a market increasingly focused on evidence-based wellness solutions. With a P/E ratio of 6.93 and a dividend yield of 3.48%, LFVN offers a potentially attractive combination of value and income. Growth catalysts include expansion into new international markets and the introduction of innovative products targeting specific health concerns. The company's high gross margin of 79.2% indicates strong pricing power and efficient operations. Successful execution of its growth strategies could drive significant revenue and earnings growth, making LFVN an attractive investment for long-term investors.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market capitalization of $0.06 billion, indicating a small-cap company with potential for growth.
  • P/E ratio of 6.93, suggesting the company may be undervalued compared to its earnings.
  • Gross margin of 79.2%, reflecting strong pricing power and efficient cost management.
  • Profit margin of 4.2%, indicating profitability and potential for further margin expansion.
  • Dividend yield of 3.48%, offering an attractive income stream for investors.

Competitors & Peers

Strengths

  • Proprietary nutrigenomic formulations.
  • Established direct selling distribution network.
  • Strong brand reputation and customer loyalty.
  • High gross margins.

Weaknesses

  • Reliance on independent distributors.
  • Limited brand awareness compared to larger competitors.
  • Vulnerability to regulatory changes in the dietary supplement industry.
  • Relatively small market capitalization.

Catalysts

  • Ongoing: Continued expansion into international markets, driving revenue growth.
  • Upcoming: Launch of new products targeting specific health concerns in Q3 2026.
  • Ongoing: Strengthening of the independent distributor network through enhanced training and support programs.
  • Upcoming: Positive results from ongoing clinical trials validating the efficacy of Protandim in Q4 2026.

Risks

  • Potential: Regulatory changes in the dietary supplement industry could impact product sales and marketing.
  • Ongoing: Dependence on the performance of independent distributors.
  • Potential: Intense competition from larger companies with greater resources.
  • Ongoing: Economic downturns could reduce consumer spending on discretionary health and wellness products.

Growth Opportunities

  • Expansion into New International Markets: LifeVantage has the opportunity to expand its presence in emerging markets, particularly in Asia and South America, where there is a growing demand for health and wellness products. By leveraging its existing distribution network and adapting its product offerings to local preferences, LifeVantage can tap into new revenue streams. The global dietary supplements market is projected to reach $230.73 billion by 2027, providing a significant opportunity for growth.
  • Product Innovation and Development: LifeVantage can drive growth by continuing to invest in research and development to create innovative products that address specific health concerns. The company's focus on nutrigenomics provides a unique platform for developing scientifically validated solutions that differentiate it from competitors. The anti-aging market, in particular, offers significant potential for new product development.
  • Enhancing Digital Marketing and E-Commerce Capabilities: LifeVantage can enhance its digital marketing efforts and e-commerce platform to reach a wider audience and drive online sales. By leveraging social media, search engine optimization, and targeted advertising, the company can increase brand awareness and attract new customers. The global e-commerce market is experiencing rapid growth, providing a significant opportunity for LifeVantage to expand its online presence.
  • Strengthening Distributor Network: LifeVantage's direct selling model relies on a strong and motivated network of independent distributors. By providing comprehensive training, support, and incentives, the company can strengthen its distributor network and increase sales productivity. Investing in technology and tools to support distributors can also enhance their effectiveness.
  • Strategic Partnerships and Acquisitions: LifeVantage can explore strategic partnerships and acquisitions to expand its product portfolio, enter new markets, and gain access to new technologies. Partnering with complementary businesses can create synergies and accelerate growth. Acquisitions can provide access to new customer segments and distribution channels.

Opportunities

  • Expansion into new international markets.
  • Development of new products targeting specific health concerns.
  • Increased adoption of e-commerce and digital marketing.
  • Strategic partnerships and acquisitions.

Threats

  • Intense competition in the dietary supplement and skincare industries.
  • Changes in consumer preferences and trends.
  • Economic downturns affecting consumer spending.
  • Negative publicity or product recalls.

Competitive Advantages

  • Proprietary formulations and patented technologies in nutrigenomics.
  • Established network of independent distributors providing personalized customer engagement.
  • Strong brand reputation built on scientific validation and clinical studies.
  • High gross margins reflecting pricing power and product differentiation.

About LFVN

LifeVantage Corporation, headquartered in Lehi, Utah, was founded with the mission to transform health, wellness, and anti-aging through scientifically validated nutrigenomics. The company identifies, researches, develops, formulates, sells, and distributes a range of products designed to optimize health at the cellular level. Its flagship product, Protandim, is a line of dietary supplements clinically shown to combat oxidative stress. Over the years, LifeVantage has expanded its product portfolio to include LifeVantage Omega+, LifeVantage ProBio, the PhysIQ weight management system, Petandim for Dogs, and Axio energy drink mixes. Additionally, the company offers the TrueScience line of anti-aging skincare and haircare products, as well as bath and body products. LifeVantage distributes its products through a network of independent distributors across the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. This direct selling model allows for personalized customer engagement and education, fostering brand loyalty and driving sales growth. With a focus on scientific validation and innovative product development, LifeVantage aims to be a leader in the nutrigenomics and wellness industry.

What They Do

  • Develop and sell nutrigenomic activators.
  • Offer dietary supplements for overall health and wellness.
  • Provide nootropics for cognitive enhancement.
  • Distribute pre- and pro-biotics for digestive health.
  • Market weight management products.
  • Offer skin and hair care products.
  • Provide bath and body products.
  • Sell targeted relief products.

Business Model

  • Develops and formulates proprietary health and wellness products.
  • Sells products through a network of independent distributors.
  • Generates revenue through direct sales to distributors and customers.
  • Focuses on recurring revenue through subscription-based programs.

Industry Context

LifeVantage operates within the global packaged foods industry, specifically targeting the dietary supplements and skincare segments. The market for dietary supplements is experiencing growth driven by increasing consumer awareness of health and wellness, as well as an aging population seeking anti-aging solutions. The competitive landscape includes both large multinational corporations and smaller niche players. LifeVantage differentiates itself through its focus on nutrigenomics and its direct selling distribution model. The company's ability to scientifically validate its products and build strong relationships with its distributors is crucial for success in this competitive environment.

Key Customers

  • Individuals seeking to improve their overall health and wellness.
  • Consumers interested in anti-aging solutions.
  • Pet owners looking for supplements to support their pets' health.
  • Independent distributors who purchase products for resale.
AI Confidence: 70% Updated: Feb 8, 2026

Financials

Chart & Info

LifeVantage Corporation (LFVN) stock price: $4.32 (+0.03, +0.70%)

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for LFVN.

Price Targets

Consensus target: $5.00

MoonshotScore

54/100

What does this score mean?

The MoonshotScore rates LFVN's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

LFVN Consumer Defensive Stock FAQ

What does LifeVantage Corporation do?

LifeVantage Corporation is a health and wellness company that develops and distributes scientifically validated nutrigenomic activators, dietary supplements, skincare products, and other related products. The company's flagship product, Protandim, is designed to combat oxidative stress at the cellular level. LifeVantage sells its products through a network of independent distributors across multiple international markets, including the United States, Mexico, Japan, and several European countries. The company focuses on providing innovative, science-backed solutions to improve health and well-being.

Is LFVN stock worth researching?

LFVN stock presents a mixed investment profile. The company's focus on nutrigenomics and its direct selling model offer growth potential. The P/E ratio of 6.93 suggests potential undervaluation, and the dividend yield of 3.48% provides an income stream. However, the small market capitalization of $0.06 billion and reliance on independent distributors pose risks. Investors should carefully consider the company's growth prospects, competitive landscape, and potential regulatory challenges before investing. Further analysis of the company's financial performance and strategic initiatives is recommended.

What are the main risks for LFVN?

The main risks for LifeVantage Corporation include regulatory changes in the dietary supplement industry, which could impact product sales and marketing. The company's reliance on independent distributors also poses a risk, as their performance directly affects revenue. Intense competition from larger companies with greater resources could limit LifeVantage's market share. Economic downturns could reduce consumer spending on discretionary health and wellness products. Additionally, negative publicity or product recalls could damage the company's brand reputation and financial performance. Effective risk management and mitigation strategies are crucial for LifeVantage's success.

What are the key factors to evaluate for LFVN?

LifeVantage Corporation (LFVN) currently holds an AI score of 54/100, indicating moderate score. The stock trades at a P/E of 6.9x, below the S&P 500 average (~20-25x), potentially signaling value. Analysts target $5.00 (+16% from $4.32). Key strength: Proprietary nutrigenomic formulations.. Primary risk to monitor: Potential: Regulatory changes in the dietary supplement industry could impact product sales and marketing.. This is not financial advice.

How frequently does LFVN data refresh on this page?

LFVN prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven LFVN's recent stock price performance?

Recent price movement in LifeVantage Corporation (LFVN) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $5.00 implies 16% upside from here. Notable catalyst: Proprietary nutrigenomic formulations.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider LFVN overvalued or undervalued right now?

Determining whether LifeVantage Corporation (LFVN) is overvalued or undervalued requires examining multiple metrics. Its P/E ratio is 6.9. Analysts target $5.00 (+16% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying LFVN?

Before investing in LifeVantage Corporation (LFVN), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Stock data pending update.
  • Analysis based on available financial data and company information.
Data Sources

Popular Stocks